A confederacy of kinases: Cdk2 and Cdk4 conspire to control embryonic cell proliferation

Philip W Hinds1

  • 1Department of Radiation Oncology, Molecular Oncology Research Institute, Tufts-New England Medical Center, Boston, Massachusetts 02115, USA.

Molecular Cell
|May 23, 2006
PubMed

Insights

Mouse embryos resist losing single cyclins or cyclin-dependent kinases. Simultaneous loss of Cdk2 and Cdk4 causes embryonic lethality by activating the retinoblastoma protein.

Area of Science:

  • Developmental Biology
  • Cell Cycle Regulation

Background:

  • Mouse embryos exhibit resistance to the loss of individual cyclins or cyclin-dependent kinases (CDKs).
  • The specific roles and redundancies of CDKs in early embryogenesis remain incompletely understood.

Purpose of the Study:

  • To investigate the collaborative roles of Cdk2 and Cdk4 in mouse embryogenesis.
  • To determine the consequences of simultaneous Cdk2 and Cdk4 loss during embryonic development.

Main Methods:

  • Analysis of mouse models with genetic deletions.
  • Assessment of cell cycle progression and protein activation in developing embryos.

Main Results:

  • Simultaneous loss of Cdk2 and Cdk4 leads to embryonic lethality.
  • The absence of both Cdk2 and Cdk4 results in the inappropriate activation of the retinoblastoma protein (Rb).
  • This highlights a functional redundancy between Cdk2 and Cdk4 in preventing premature Rb activation.

Conclusions:

  • Cdk2 and Cdk4 collaborate to regulate cell cycle progression during mouse embryogenesis.
  • Their combined function is essential for preventing embryonic lethality, mediated through the control of retinoblastoma protein activity.

Related Concept Videos

Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibition of CDK Activity02:34

Inhibition of CDK Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Positive Regulator Molecules02:39

Positive Regulator Molecules

Mitotic cell division results in daughter cells that exactly resemble the parent cell. However, errors in the DNA replication or distribution of genetic material may lead to genetic mutations that may be passed down to every new cell formed from the resulting abnormal cell. Propagation of such mutant cells is restricted through checkpoint mechanisms present at different stages of the cell cycle. These checkpoints involve regulator molecules that either promote or demote cell cycle events.
Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
M-Cdk Drives Transition Into Mitosis02:15

M-Cdk Drives Transition Into Mitosis

Checkpoints throughout the cell cycle serve as safeguards and gatekeepers, allowing the cell cycle to progress in favorable conditions and slow or halt it in problematic ones. This regulation is known as the cell cycle control system.
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...